Citations

Showing 10 of 108083 citations.

Environmental impact of single‐use and reusable flexible cystoscopes
Kemble, Jayson , Matlaga, Brian R., Potretzke, Aaron M. , Koo, Kevin , Kemble, Jayson P , Koo, Kevin , Winoker, Jared S. , Patel, Sunil , Su, Zhuo T.

Mayo Clinic

BJU International | December 14, 2022 | Volume: 131 | Issue: 5 | Pages: 617-622

10.1111/bju.15949 | PMID 36515438 Get It

Objectives To compare the carbon footprint and environmental impact of single‐use and reusable flexible cystoscopes. Materials and Methods We analysed the expected clinical lifecycle of single‐use (Ambu aScope™ 4 Cysto) and reusable (Olympus CYF‐V2) flexible cystoscopes, from manufacture to disposal. Performance data on cumulative procedures between repairs and before decommissioning were derived from a high‐volume multispecialty practice. We estimated carbon expenditures per‐case using published data on endoscope manufacturing, energy consumption during transportation and reprocessing, and solid waste disposal. Results A fleet of 16 reusable cystoscopes in service for up to 135 months averaged 207 cases between repairs and 3920 cases per lifecycle. Based on a manufacturing carbon footprint of 11.49 kg CO 2 /kg device for reusable flexible endoscopes and 8.54 kg CO 2 /kg device for single‐use endoscopes, the per‐case manufacturing cost was 1.37 kg CO 2 for single‐use devices and 0.0017 kg CO 2 for reusable devices. The solid mass of single‐use and reusable devices was 0.16 and 0.57 kg, respectively. For reusable devices, the energy consumption of reusable device reprocessing using an automated endoscope reprocessor was 0.20 kg CO 2 , and per‐case costs of device repackaging and repair were 0.005 and 0.02 kg CO 2 , respectively. The total estimated per‐case carbon footprint of single‐use and reusable devices was 2.40 and 0.53 kg CO 2 , respectively, favouring reusable devices. Conclusion In this lifecycle analysis, the environmental impact of reusable flexible cystoscopes is markedly less than single‐use cystoscopes. The primary contributor to the per‐case carbon cost of reusable devices is energy consumption of reprocessing.
Careful, kind care is our compass out of the pandemic fog
Allwood, Dominique , Montori, Víctor M.

Mayo Clinic

BMJ | December 14, 2022 | Volume: 379 | Issue: No issue available | Pages: e073444

10.1136/bmj-2022-073444 | PMID 36517069 Get It

Activation of a Latent Epitope Causing Differential Binding of Antineutrophil Cytoplasmic Antibodies to Proteinase 3
Moura, Marta Casal , Thompson, Gwen , Nelson, Darlene R. , Fussner, Lynn A. , Hummel, Amber M., Jenne, Dieter E. , Emerling, Daniel , Kallenberg, Cees G. M., Langford, Carol A. , McCune, W. Joseph, Clair, E. William St. , Ytterberg, Steven R. , Stone, John H. , Robinson, William H. , Casal Moura, Marta , Thompson, Gwen E, Merkel, Peter A , Monach, Paul A , Spiera, Robert F , Stone, John H , Robinson, William H , Fervenza, Fernando C. , Merkel, Peter A. , Monach, Paul A. , Seo, Philip , Spiera, Robert , Specks, Ulrich

Mayo Clinic

Arthritis & Rheumatology | December 14, 2022 | Volume: 75 | Issue: 5 | Pages: 748-759

10.1002/art.42418 | PMID 36515151 Get It

Objective Proteinase 3 (PR3) is the major antigen for antineutrophil cytoplasmic antibodies (ANCAs) in the systemic autoimmune vasculitis, granulomatosis with polyangiitis (GPA). PR3‐targeting ANCAs (PR3‐ANCAs) recognize different epitopes on PR3. This study was undertaken to study the effect of mutations on PR3 antigenicity. Methods The recombinant PR3 variants, iPR3 (clinically used to detect PR3‐ANCAs) and iHm5 (containing 3 point mutations in epitopes 1 and 5 generated for epitope mapping studies) immunoassays and serum samples from patients enrolled in ANCA‐associated vasculitis (AAV) trials were used to screen for differential PR3‐ANCA binding. A patient‐derived monoclonal ANCA 518 (moANCA518) that selectively binds to iHm5 within the mutation‐free epitope 3 and is distant from the point mutations of iHm5 was used as a gauge for remote epitope activation. Selective binding was determined using inhibition experiments. Results Rather than reduced binding of PR3‐ANCAs to iHm5, we found substantially increased binding of the majority of PR3‐ANCAs to iHm5 compared to iPR3. This differential binding of PR3‐ANCA to iHm5 is similar to the selective moANCA518 binding to iHm5. Binding of iPR3 to monoclonal antibody MCPR3‐2 also induced recognition by moANCA518. Conclusion The preferential binding of PR3‐ANCAs from patients, such as the selective binding of moANCA518 to iHm5, is conferred by increased antigenicity of epitope 3 on iHm5. This can also be induced on iPR3 when captured by monoclonal antibody MCPR2. This previously unrecognized characteristic of PR3‐ANCA interactions with its target antigen has implications for studying antibody‐mediated autoimmune diseases, understanding variable performance characteristics of immunoassays, and design of potential novel treatment approaches. image
Central versus Peripheral Postcardiotomy Veno-Arterial Extracorporeal Membrane Oxygenation: Systematic Review and Individual Patient Data Meta-Analysis
Biancari, Fausto , Kaserer, Alexander , Perrotti, Andréa , Cho, Sung‐Min , Kang, Jin Kook, Dalén, Magnus , Welp, Henryk , Jónsson, Kristján , Pérez, Francisco José Hernández, Gatti, Giuseppe , Alkhamees, Khalid , Loforte, Antonio , Rosato, Stefano , Spadaccio, Cristiano , Pettinari, Matteo , Fiore, Antonio , Mäkikallio, Timo , Sahli, Sebastian D. , L’Acqua, Camilla , AlBarak, Mohammed M, Laimoud, Mohamed , Djordjevic, Ilija , Krasivskyi, Ihor , Samalavičius, Robertas , Alonso-Fernández-Gatta, Marta , Wilhelm, Markus J. , Cho, Sung-Min , Dalén, Magnus , Welp, Henryk , Jónsson, Kristján , Gatti, Giuseppe , Loforte, Antonio , Rosato, Stefano , Pettinari, Matteo , Fiore, Antonio , Sahli, Sebastian D , L'Acqua, Camilla , Laimoud, Mohamed , Djordjevic, Ilija , Krasivskyi, Ihor , Alonso-Fernandez-Gatta, Marta , Samalavicius, Robertas , Ruggieri, Vito Giovanni , Kang, Jin Kook , Ragnarsson, Sigurður , Lechiancole, Andrea , Arafat, Amr A , Albabtain, Monirah Abdulrahman , Puodžiukaitė, Lina , Mariscalco, Giovanni

Mayo Clinic

Journal of Clinical Medicine | December 14, 2022 | Volume: 11 | Issue: 24 | Pages: 7406

10.3390/jcm11247406 | PMID 36556021 Get It

Background: It is unclear whether peripheral arterial cannulation is superior to central arterial cannulation for postcardiotomy veno-arterial extracorporeal membrane oxygenation (VA-ECMO). Methods: A systematic review was conducted using PubMed, Scopus, and Google Scholar to identify studies on postcardiotomy VA-ECMO for the present individual patient data (IPD) meta-analysis. Analysis was performed according to the intention-to-treat principle. Results: The investigators of 10 studies agreed to participate in the present IPD meta-analysis. Overall, 1269 patients were included in the analysis. Crude rates of in-hospital mortality after central versus peripheral arterial cannulation for VA-ECMO were 70.7% vs. 63.7%, respectively (adjusted OR 1.38, 95% CI 1.08–1.75). Propensity score matching yielded 538 pairs of patients with balanced baseline characteristics and operative variables. Among these matched cohorts, central arterial cannulation VA-ECMO was associated with significantly higher in-hospital mortality compared to peripheral arterial cannulation VA-ECMO (64.5% vs. 70.8%, p = 0.027). These findings were confirmed by aggregate data meta-analysis, which showed that central arterial cannulation was associated with an increased risk of in-hospital mortality compared to peripheral arterial cannulation (OR 1.35, 95% CI 1.04–1.76, I2 21%). Conclusions: Among patients requiring postcardiotomy VA-ECMO, central arterial cannulation was associated with an increased risk of in-hospital mortality compared to peripheral arterial cannulation. This increased risk is of limited magnitude, and further studies are needed to confirm the present findings and to identify the mechanisms underlying the potential beneficial effects of peripheral VA-ECMO.
Primary Pulmonary Hyalinizing Clear Cell Carcinoma: Case Series With Review of Literature
Thakur, Shilpi , Nambirajan, Aruna , Larsen, Brandon T. , Butt, Yasmeen M. , Roden, Anja C. , Kumar, Sunil, Jain, Deepali , Jain, Deepali

Mayo Clinic

International Journal of Surgical Pathology | December 14, 2022 | Volume: 31 | Issue: 7 | Pages: 1187-1194

10.1177/10668969221137516 | PMID 36514272 Get It

Background: Hyalinizing clear cell carcinomas of tracheobronchial origin are very rare salivary gland type tumors accounting for less than 1% of lung tumors with only 13 cases reported to date. Their radiological features, morphological spectrum, and molecular features are not well described. Aim: To perform a clinicopathological analysis of primary pulmonary hyalinizing clear cell carcinomas. Method: A retrospective search of primary pulmonary hyalinizing clear cell carcinomas was conducted from authors’ institutions and the clinicopathological features including details of molecular testing were analyzed. Results: Five primary pulmonary hyalinizing clear cell carcinomas were identified. The mean patient age at diagnosis was 48.2 years (range: 33-64 years). Three patients were women. All patients were nonsmokers and 3 were symptomatic; 2 were detected incidentally during health screening. The tumors were located in the main lobar bronchi ranging from 1.3 to 4.9 cm in maximum dimension. Microscopy showed cords and nests of at least, focally clear tumor cells. Mucin cysts lacking goblet cells were seen. All tumors were uniformly positive for p40, p63, AE1/AE3, keratin 7, and epithelial membrane antigen but negative for TTF1, KIT, neuroendocrine markers, and other myoepithelial markers. All cases showed Ewing sarcoma breakpoint region 1 ( EWSR1) gene rearrangement. Perineural invasion and lymph node metastases were detected in patient 5. Two patients with available follow-up data were recurrence-free until 4 years (patient 1) and 9 months (patient 5) after resection. Conclusion: The present series adds to the scant available literature on primary pulmonary hyalinizing clear cell carcinomas highlighting the characteristic histomorphology, immunoprofiles, and benign outcomes of these rare tumors.
AAPM Task Group Report 306: Quality control and assurance for tomotherapy: An update to Task Group Report 148
Chen, Quan , Burmeister, Jay , Chao, Edward, Corradini, Nathan, Followill, D , Liu, An , Qi, X. Sharon , Shi, Hai-Rong, Smilowitz, Jennifer B., Rong, Yi , Li, X. Allen , Shi, Hairong, Smilowitz, Jennifer B.

Mayo Clinic

Medical Physics | December 13, 2022 | Volume: 50 | Issue: 3 | Pages: No page available

10.1002/mp.16150 | PMID 36512742 Get It

AbstractSince the publication of AAPM Task Group (TG) 148 on quality assurance (QA) for helical tomotherapy, there have been many new developments on the tomotherapy platform involving treatment delivery, on‐board imaging options, motion management, and treatment planning systems (TPSs). In response to a need for guidance on quality control (QC) and QA for these technologies, the AAPM Therapy Physics Committee commissioned TG 306 to review these changes and make recommendations related to these technology updates. The specific objectives of this TG were (1) to update, as needed, recommendations on tolerance limits, frequencies and QC/QA testing methodology in TG 148, (2) address the commissioning and necessary QA checks, as a supplement to Medical Physics Practice Guidelines (MPPG) with respect to tomotherapy TPS and (3) to provide risk‐based recommendations on the new technology implemented clinically and treatment delivery workflow. Detailed recommendations on QA tests and their tolerance levels are provided for dynamic jaws, binary multileaf collimators, and Synchrony motion management. A subset of TPS commissioning and QA checks in MPPG 5.a. applicable to tomotherapy are recommended. In addition, failure mode and effects analysis has been conducted among TG members to obtain multi‐institutional analysis on tomotherapy‐related failure modes and their effect ranking.
Out-of-State Students at State Medical Schools and Increasing Medical Education Debt
Hasan, Shaina, Buckner‐Petty, Skye , Files, Julia A. , LeMond, Lisa , Buckner-Petty, Skye A, Lemond, Lisa M, Kraus, Molly B. , Hayes, Sharonne N. , Habermann, Elizabeth B.

Mayo Clinic

Academic Medicine | December 13, 2022 | Volume: 98 | Issue: 5 | Pages: 595-605

10.1097/acm.0000000000005079 | PMID 36512837 Get It

Abstract Purpose Medical school tuition has increased at alarming rates ahead of inflation over the past 20 years. The authors investigated whether state-funded medical schools have had an increased number of out-of-state matriculants, which may create a diaspora of displaced in-state medical students matriculating to out-of-state programs and incurring substantial debt. Method Publicly available data from the Association of American Medical Colleges (AAMC) were accessed from 2004 through 2019 for applicants and matriculants at U.S. state-funded schools. Schools listed as public that reported tuition charges in the AAMC Tuition and Student Fees reports were included in this study. The numbers and trends of medical school applications and trends in tuition costs and average indebtedness were summarized for in-state and out-of-state matriculants. Values were analyzed by group as median and interquartile range (IQR). Group differences were assessed via t tests. P values less than .05 were considered statistically significant. Results From 2004 through 2019, the annual number of out-of-state matriculants in state-funded schools increased 7% (16%–23% [7,195–11,144]). Among 74 schools with data in 2004, the median percentage of out-of-state applications increased from 60% (IQR, 31%–74%) to 80% (IQR, 57%–85%; P < .001), and the median percentage of out-of-state matriculants increased from 13% (IQR, 5%–23%) to 17% (IQR, 11%–33%; P < .001). In 2004, the mean (standard error) debt upon completion of medical school (inflation adjusted to 2018 dollars) was $144,100 ($10,950); by 2016, the mean debt had increased to $251,600 ($32,040), a 75% increase over 12 years. Conclusions Since 2004, substantial increases have occurred in out-of-state matriculants at state-funded medical schools. This may displace residents from attending their in-state schools, causing them to attend out-of-state or private medical schools, where tuition is typically much higher.
Physicians Must Be Committed to Actively Deconstructing the Gender Binary
Melson, Valerie A. , Melson, Valerie

Mayo Clinic

Academic Medicine | December 13, 2022 | Volume: 98 | Issue: 7 | Pages: 760-761

10.1097/acm.0000000000005103 | PMID 36512840 Get It

Fitting In While Standing Out: Professional Identity Formation, Imposter Syndrome, and Burnout in Early-Career Faculty Physicians
Stelling, Brianna E. Vaa , Andersen, Carl A, Nordhues, Hannah C. , Hafferty, Frederic W. , Beckman, Thomas J. , Sawatsky, Adam P. , Vaa Stelling, Brianna E, Suarez, Diego A. , Andersen, Carl , Suarez, Diego A

Mayo Clinic

Academic Medicine | December 13, 2022 | Volume: 98 | Issue: 4 | Pages: 514-520

10.1097/acm.0000000000005049 | PMID 36512808 Get It

Abstract Purpose Professional identity formation (PIF) is a dynamic process by which an individual internalizes the core values and beliefs of a specific profession. Within medical education, PIF begins in medical school and continues throughout training and practice. Transitions affect PIF, with a critical transition occurring between medical training and unsupervised practice. This study aims to characterize PIF during the transition from resident to early-career faculty physician and explores the relationship between PIF and burnout during this transition. Method The authors conducted a qualitative study using constructivist grounded theory. They conducted semistructured interviews with early-career faculty physicians (defined as practicing for ≤ 5 years) from the Department of Medicine, Mayo Clinic. Deidentified interview transcripts were processed through open and axial coding. The authors organized themes and identified relationships between themes that were refined through discussion and constant comparison with newly collected data. During data analysis, the authors identified self-determination theory, with the concepts of autonomy, competence, and relatedness, as a framework to support the organization and analysis of the data. Results Eleven early-career faculty physicians participated in the interviews. Their PIF was characterized by the dual desires to fit in and stand out. Striving for these desires was characterized by imposter syndrome, driving physicians to question their decision making and overall competence. Participants associated imposter syndrome and academic pressures with burnout. Autonomy support by the institution to pursue opportunities important for career development helped mitigate burnout and support PIF. Conclusions Early-career faculty physicians face identity challenges when transitioning from training to unsupervised practice, including striving to fit in and stand out. They link this tension to imposter syndrome, which they associated with burnout. Institutional awareness and support, including addressing structural and cultural contributors to imposter syndrome, are paramount as new faculty explore their identities and navigate new challenges.
Stereotactic Radiosurgery for Intraventricular Metastases: A Multicenter Study
Mantziaris, Georgios , Pikis, Stylianos , Xu, Zhiyuan , Mullen, Reed, Bernstein, Kenneth , Wei, Zhishuo , Niranjan, Ajay , Lunsford, L. Dade , May, Jaromír , Lee, Cheng-chia, Coupé, François-Louis, Mathieu, David , Sheehan, Kimball , Sheehan, Darrah, Perlow, Haley K. , Peker, Selçuk , Samancı, Yavuz , Peterson, Jennifer , Shepard, Matthew J., Elhamdani, Shahed, Wegner, Rodney E. , Hernández, Wenceslao, Warnick, Ronald E. , Sheehan, Jason P. , Mathieu, David , Mantziaris, Georgios , Perlow, Haley K , Alzate, Juan Diego , Kondziolka, Douglas , Liščák, Roman , Yang, Huai‐Che , Palmer, Joshua D. , Trifiletti, Daniel M. , Elhamdani, Shahed, Speckter, Herwin

Mayo Clinic

Neurosurgery | December 13, 2022 | Volume: 92 | Issue: 3 | Pages: 565-573

10.1227/neu.0000000000002248 | PMID 36512817 Get It

BACKGROUND: Intraventricular metastases (IVMs) are uncommon, and their optimal management remains debatable. OBJECTIVE: To define the safety and efficacy of stereotactic radiosurgery (SRS) in the treatment of IVMs. METHODS: This retrospective, multicenter study included patients managed with SRS for IVMs. SRS-induced adverse events, local tumor or intracranial progression, and the frequency of new-onset hydrocephalus or leptomeningeal spread were documented. Analyses of variables related to patient neuroimaging or clinical outcomes were also performed. RESULTS: The cohort included 160 patients from 11 centers who underwent SRS for treatment of 1045 intracranial metastases, of which 196 were IVMs. The median survival from SRS was 10 months. Of the 154 patients and 190 IVMs with imaging follow-up, 94 patients (61%) experienced distant intracranial disease progression and 16 IVMs (8.4%) progressed locally. The 12- and 24-month local IVM control rates were 91.4% and 86.1%, respectively. Sixteen (10%) and 27 (17.5%) patients developed hydrocephalus and leptomeningeal dissemination post-SRS, respectively. Adverse radiation effects were documented in 24 patients (15%). Eleven patients (6.9%) died because of intracranial disease progression. CONCLUSION: SRS is an effective treatment option for IVMs, with a local IVM control rate comparable with SRS for parenchymal brain metastases. Leptomeningeal spread and hydrocephalus in patients with IVM occur in a minority of patients, but these patients warrant careful follow-up to detect these changes.